Acquisitions (Tables)

3 Months Ended

Mar. 31, 2023

Business Combinations [Abstract]

Schedule of Components and Fair Value Allocation of the Consideration Transferred in Connection with Acquisitions

The components and fair value allocation of the consideration transferred in connection with the acquisition are as follows (in millions):

Consideration Transferred:
Cash paid	$	73.6
Cash acquired		(9.5	)
Holdback		0.2
Fair value of redeemable noncontrolling interest		2.3
Total consideration transferred	$	66.6
Allocation of Consideration Transferred:
Accounts receivable	$	3.6
Inventories		0.4
Other current assets		0.9
Property, plant and equipment		8.0
Other assets		4.2
Intangible assets:
Technology		10.2
Customer relationships		13.8
Trade name		2.7
Backlog		0.8
Goodwill		48.1
Liabilities assumed (a)		(26.1	)
Total consideration allocated	$	66.6

(a) This amount includes assumed liability for employee awards of $6.3 million on acquisition date and was settled in the post-closing period ended March 31, 2023.

Schedule of Consideration Transferred and the Respective Reporting Segment for Each Acquisition

In addition to the Biognosys acquisition, during the three months ended March 31, 2023, the Company completed various other acquisitions accounted for under the acquisition method that complemented the Company’s existing product offerings. The following table reflects the consideration transferred and the respective reporting segment for the acquisitions (in millions):

Name of Acquisition	Date Acquired	Segment	Total Consideration		Cash Consideration
Acquifer Imaging GmbH and Deltabyte GmbH	January 4, 2023	BSI Nano	$	7.6	$	7.6
Other majority owned acquisitions	Various	BSI CALID		19.1		12.2
			$	26.7	$	19.8

In addition to the acquisitions noted above, during the three months ended March 31, 2023, the Company completed minority investments that complemented the Company's existing product offerings. The following table reflects the consideration transferred and the respective reporting segment for the investments (in millions):

Name	Acquisition / Investment	Financial Statement Classification	Date Acquired	Segment	Total Consideration		Cash Consideration
Other Investments	Investment	Other long-term assets	Various	Various	$	8.2	$	8.2
					$	8.2	$	8.2